Posted by utopizen on January 20, 2003, at 7:34:08
In reply to Re: gabitril neurontin etc, posted by missliz on January 20, 2003, at 2:19:02
you possible misread the New York Times.
They never said the indications didn't work. And controlled studies do prove its efficacy in many off-label uses, contradicting your statements.
The article simply said the company knew the drug wasn't FDA approved for the indications marketed. An FDA approval for an indication is a marketing approval in nature, meaning it simply means the FDA will allow the company to market it for a specific indication. It does NOT mean simply because the FDA didn't approve a drug for a certain indication that the drug is useless for the unapproved indication.
And I do not know of a single doctor who considers Neurontin unsafe. The is actually one of the more tolerated drugs out there, with a very favorable toxicity rating.
poster:utopizen
thread:136541
URL: http://www.dr-bob.org/babble/20030119/msgs/136704.html